logo
Have to deliver maximum planes to IndiGo, AI: Airbus

Have to deliver maximum planes to IndiGo, AI: Airbus

Time of India2 days ago

NEW DELHI: For Airbus, IndiGo and Air India are now among the top three airline customers globally with the maximum backlog or aircraft yet to be delivered, according to the aerospace major's EVP (sales, commercial aircraft) Benoit de Saint-Exupery.
It has to deliver 916 and 344 aircraft, majority of which are narrow body, to IndiGo and AI, respectively, said an official. Malaysia-based AirAsia Group, which once used to run a JV airline in India with the Tatas, is at the second spot at 393 planes.
In Delhi for the IATA AGM, Benoit had some good news for airlines that are getting increasingly frustrated with delivery delays (including from Boeing too). "We are seeing the first signs of stability in supply chain.
We (are) now back to the pre-Covid level of producing 60 A320 family of single aisle planes every month and hope to increase this number to 75 by 2027. We have the orders and are ramping up production and every commercial (Airbus) aircraft that's flying going forward will be made partly made in India," Benoit said.
Asked if the order book for 1,750 planes from IndiGo and AI makes a case for India to get a final assembly line (FAL), Benoit said: "We will have final assembly lines on the other products (one for H125 helicopters for its civil range and other for C295 military aircraft).
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Anvisa aprova solução para ajudar a reduzir gordura visceral da barriga em 7 dias!
Você Mais Saudável Hoje
Saiba Mais
Undo
On commercial aircraft side, we are looking at expanding our footprint with industry here in India. Sourcing from India has much value than an FAL for commercial aircraft and we are constantly increasing the same from here.
Airbus sourcing from India was $500 millon in 2020. We crossed the $1-billion mark in 2023 and last year we were at $1.4 billion. We will reach $ 2 billion before the end of the decade."
Remi Maillard, president of Airbus India and MD of south Asia region, said: "India is not only a market for us.
It has become a strategic resource and industrial base for Airbus."
About delays in aircraft deliveries due to supply chain issues, Benoit said: "Now we are seeing the first signs of stability in the supply chain. But you, you never quite rest because, as we all know, the situation can change quite quickly nowadays."
Stay informed with the latest
business
news, updates on
bank holidays
and
public holidays
.
AI Masterclass for Students. Upskill Young Ones Today!– Join Now

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

'OpenAI Academy India' launched to help expand access to AI skills
'OpenAI Academy India' launched to help expand access to AI skills

Hans India

time35 minutes ago

  • Hans India

'OpenAI Academy India' launched to help expand access to AI skills

New Delhi: OpenAI, in partnership with the government's IndiaAI mission, on Thursday launched the first international expansion of its education platform, that will help expand access to AI skills training across the country. The initiative, called 'OpenAI Academy India', aims to broaden access to AI education and tools, tapping into India's fast-growing developer community, digital infrastructure, and network of startups and innovators. It will support the IndiaAI Mission's 'FutureSkills' pillar by expanding access to AI skills training for a wide range of learners — students, developers, educators, civil servants, nonprofit leaders, and small business owners. The initiative offers a combination of digital and in-person learning, tailored to India's needs and available in English and Hindi, with additional regional languages to follow. 'This is a significant step towards advancing our shared goal of democratizing access to knowledge and technology. Under the visionary leadership of Prime Minister Narendra Modi, India is committed to ensuring that the benefits of cutting-edge innovation reach every citizen,' said Ashwini Vaishnaw, Union Minister for Information and Broadcasting and Electronics and IT. 'We believe the latest AI frameworks and tools must be made widely accessible so that our startups, developers, and researchers can build faster, better, and at scale. The launch of OpenAI Academy will strengthen India's AI Mission by enabling greater community learning, fostering innovation, and accelerating the development of locally relevant solutions,' Vaishnaw noted. OpenAI will provide its educational content to be hosted on the iGOT Karmayogi platform, aimed at capacity building of government officials. This content will initially be in English and Hindi and will later be expanded to 4 other regional languages. OpenAI will also conduct periodic webinars and in-person workshops, delivered by its domain experts and partners in six cities. It will provide up to $100,000 worth of API Credits to 50 IndiaAI Mission approved fellows/startups. OpenAI said it will also support training of 1 million teachers in the use of Generative AI technology. 'India is one of the most dynamic countries in the world for AI development, with adoption and innovation accelerating at remarkable speed,' said Jason Kwon, Chief Strategy Officer, OpenAI. 'We're proud to partner with IndiaAI to launch OpenAI Academy India and help more people gain the confidence and skills to use AI meaningfully in their work, communities, and lives,' Kwon added.

Wockhardt eyes $9 bn market opportunity for novel antibiotic Zaynich
Wockhardt eyes $9 bn market opportunity for novel antibiotic Zaynich

Business Standard

time41 minutes ago

  • Business Standard

Wockhardt eyes $9 bn market opportunity for novel antibiotic Zaynich

Mumbai-based pharmaceutical major Wockhardt, which is set to launch a new class of antibiotic, Zaynich, in India this year, estimates a total addressable market opportunity of $9 billion. This includes a $7-billion market in the US and Europe, and a ₹17,000-crore opportunity in India. The company's stock rose 2.4 per cent on the BSE on Thursday following an investor presentation outlining its growth plans for the next three to five years. Zaynich (or WCK 5222) is a key research candidate in Wockhardt's pipeline. It has completed global Phase 3 clinical trials, demonstrating a 20 per cent higher (statistically superior) composite cure rate compared to Meropenem, the current gold standard in antibiotics. Wockhardt claims Zaynich is the first new class of antibiotic in over 30 years to treat gram-negative infections. The drug has already saved 51 lives under compassionate use, including three in the US, where patients had failed all existing therapies. Zaynich is indicated for complicated urinary tract infections (UTIs), hospital-acquired and ventilator-associated bacterial pneumonia, bloodstream infections, and complicated intra-abdominal infections. The company expects approval from the Drugs Controller General of India (DCGI) shortly and plans to launch the drug in the second half of this financial year. Wockhardt has completed a pre-NDA (New Drug Application) meeting with the US Food and Drug Administration (USFDA) in May and plans to file in Q2FY26, targeting a potential launch in FY27. Regulatory filings in the EU and emerging markets are scheduled for the second half of FY26. Wockhardt estimates that around 1.1 million patients in India may benefit from Zaynich, while 371,000 carbapenem-resistant cases in the US and Europe are potential candidates. Overall, there are 4.3 million hospitalised cases involving key gram-negative pathogens in the US and EU. The firm sees a combined addressable patient pool of 2 million across India, the US, Europe, and China. Apart from Zaynich, Wockhardt is also betting on other antibiotics in its portfolio, such as Miqnaf (Nafithromycin), and its biotechnology portfolio, including insulin products. Miqnaf, already launched in India, treats community-acquired bacterial pneumonia (CABP) and upper respiratory tract infections. It has received Qualified Infectious Disease Product (QIDP) status from the USFDA, signifying unmet medical need, and Breakthrough Medicinal Product (BMP) designation in Saudi Arabia. Miqnaf targets a ₹10,800-crore market in India, with over 96 million potential prescriptions. In the biosimilars segment, Wockhardt is focusing on diabetes care and sees significant opportunity arising as Danish major Novo Nordisk phases out human insulin cartridges. This creates a ₹450-crore opportunity in India and a $157-million market across emerging economies. With only three major players in India, including itself, Wockhardt expects to benefit substantially. The company is doubling its diabetes biosimilars capacity over the next three years to meet growing demand, targeting business growth of 20–25 per cent.

Apple inks 10-yr Rs 17.4 lakh/month retail deal in Borivali's Sky City Mall
Apple inks 10-yr Rs 17.4 lakh/month retail deal in Borivali's Sky City Mall

Business Standard

time42 minutes ago

  • Business Standard

Apple inks 10-yr Rs 17.4 lakh/month retail deal in Borivali's Sky City Mall

Apple India has secured a premium commercial lease for a retail unit at Sky City Mall, Borivali East, Mumbai, marking a significant addition to its offline footprint in the city. According to property registration documents accessed by CRE Matrix, a data-driven real estate firm, the company has leased the unit for 10 years and 10 months with a monthly rent of Rs 17.35 lakh and a security deposit of over Rs 1.04 crore. The lease agreement was officially registered on May 28, 2025, and covers a carpet area of 12,616 sq. ft., including five car parkings. The starting rent per sq. ft. is set at Rs 138 per square feet, with rent escalation fixed at 15% every three years. Apple will benefit from a 10-month rent-free period, after which the rent will commence. Notably, the lock-in period spans the entire lease duration for the licensor, while the licensee (Apple) has a lock-in of 6 years and 6 months. The agreement also includes a revenue share clause, with Apple committing to share 2% of quarterly revenue for the first 42 months, which will increase to 2.5% thereafter. Additionally, Common Area Maintenance (CAM) charges have been set at ₹75 per sq. ft. "From flagship stores in BKC and Saket to now leasing at ₹138 per sq. ft. in Borivali's Sky City Mall, Apple's retail strategy in India is clearly evolving. This ₹17 lakh-a-month lease with a ₹1 crore-plus deposit shows that the brand sees value not just in prestige locations, but in high-potential suburban hubs. As real estate data analysts, we view this as a turning point—global brands are starting to chase footfalls and formats over just pin codes," said Abhishek Kiran Gupta, CEO & Co-founder, CRE Matrix. Sky City Mall, located off the Western Express Highway in Borivali East, is a strategic commercial hub with excellent metro and road connectivity. Apple's move to expand in this suburban hotspot underscores its commitment to tapping into growing retail demand in India's financial capital. This is Apple's India fourth store in the country. Earlier this year, Apple had leased an office spread over 6,526 sq ft in Mumbai's business district Bandra-Kurla Complex (BKC) through a lease at monthly rentals of Rs 738 per sq ft. According to the documents, Apple India Private Limited, the Indian arm of US-based multinational technology company headquartered in Cupertino, California, has leased the commercial space in a building named Maker Maxity-5 for five to the documents, Agni Commex LLP (the landlord) leased the space for Rs 48.19 lakh per month and Apple India paid a deposit of Rs 4.33 crore.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store